论文部分内容阅读
目的：研究东麦克栓酶治疗老年人急性脑梗塞的疗效．方法：将对７２老年脑梗塞病人分为观察组和对照组，采用随机、单盲对照试验．观察组用东菱克栓酶治疗，对照组进行常规治疗，观察治疗前后临床疗效、ＰＴ、血小板、红细胞压积及副作用．结果：治疗组临床症状改善明显，治愈率为９２．１％，与对照组比较有显著性差异（Ｐ＜０．０１）．治疗组治疗后ＰＴ延长，红细胞压积下降，与治疗前比较存在差异（Ｐ＜０．０５）．治疗前后血小板无明显变化．结论：东菱克栓酶治疗老年脑梗塞效果显著、安全、无明显副作用．
Objective: To study the effect of Dong Mai Ke thrombin in the treatment of acute cerebral infarction in the elderly. Methods: 72 senile patients with cerebral infarction were divided into observation group and control group, using a randomized, single-blind controlled trial. The observation group was treated with rhizoma corydalis, the control group was treated routinely, and the clinical efficacy, PT, platelet, hematocrit and side effects were observed before and after treatment. Results: The clinical symptoms of the treatment group improved obviously. The cure rate was 92.1%, which was significantly different from the control group (P <0.01). Treatment group PT prolonged, hematocrit decreased, compared with before treatment there are differences (P <0.05). No significant changes in platelet before and after treatment. Conclusion: Bollzyme rhubarb treatment of cerebral infarction in elderly patients with significant effect, safe, no obvious side effects.